4.6 Article

STAT1 expression and activation is increased in lesional psoriatic skin

期刊

BRITISH JOURNAL OF DERMATOLOGY
卷 168, 期 2, 页码 302-310

出版社

WILEY
DOI: 10.1111/bjd.12049

关键词

-

资金

  1. Novo Nordisk Foundation
  2. Aage Bang Foundation
  3. Lundbeck Foundation
  4. Danish Medical Research Council

向作者/读者索取更多资源

Background The JAK (Janus kinase)/STAT (signal transducer and activator of transcription) signalling pathway is known to play an important role in many cellular processes including inflammation. The activation of STAT1 is dependent on tyrosine 701 and serine 727 phosphorylation, which leads to the formation of the STAT dimer and modulation of STAT1 activity, respectively. Objective To determine STAT1 expression and activation in psoriatic skin. Methods Biopsies were collected from patients with psoriasis. mRNA expression was evaluated by quantitative polymerase chain reaction, whereas the protein and phosphorylation level of STAT1 were evaluated by Western blotting. STAT1 localization was determined by immunofluorescence analysis and STAT1-induced transcriptional activity was analysed in cultured human keratinocytes using a reporter assay. Results The expression of STAT1 was demonstrated to be significantly increased at both mRNA and protein level in lesional psoriatic skin. In addition, the phosphorylation level of STAT1(Tyr701) and STAT1(Ser727) was significantly increased in lesional compared with nonlesional psoriatic skin. Luciferase assays showed a significant induction of the STAT1-induced transcriptional activity when cultured human keratinocytes were stimulated with either interferon (IFN)-alpha or IFN-gamma. STAT1(Ser727) phosphorylation induced by IFN-alpha, IFN-gamma or ultraviolet B was mediated by a protein kinase C (PKC) delta and p38 mitogen-activated protein kinase-dependent mechanism in human keratinocytes, whereas IFN-alpha-induced STAT1(Tyr701) phosphorylation was mediated by a PKC-delta-dependent mechanism. Conclusions This study demonstrates for the first time that the phosphorylation level of STAT1(Tyr701) and STAT1(Ser727) is increased in lesional psoriatic skin. In addition, specific signalling pathways leading to this phosphorylation have been identified. Together, our data indicate an important role of STAT1 in the pathogenesis of psoriasis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

Maria Gluud, Emil M. H. Pallesen, Terkild B. Buus, Lise Mette Rahbek Gjerdrum, Lise M. Lindahl, Maria R. Kamstrup, Michael Bzorek, Maria Danielsen, Rikke Bech, Madalena N. Monteiro, Edda Blumel, Andreas Willerslev-Olsen, Anders Lykkebo-Valloe, Chella Krishna Vadivel, Thorbjorn Krejsgaard, Charlotte Menne Bonefeld, Carsten Geisler, Juergen C. Becker, Sergei B. Koralov, Lars Iversen, Thomas Litman, Anders Woetmann, Niels Odum

Summary: Cutaneous T-cell lymphoma (CTCL) is a devastating lymphoid malignancy characterized by the accumulation of malignant T cells in the dermis and epidermis. Skin lesions cause serious symptoms and increase the risk of bacterial infection. The study found that malignant T cells secrete cytokines that downregulate the expression of filaggrin and filaggrin-2, leading to compromised skin barrier. Treatment with JAK inhibitors can reverse this effect and increase filaggrin expression in patients with advanced CTCL.
Article Dermatology

Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis

Cathrine Dawn Buttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler

Summary: This study retrospectively analyzed the drug survival and effectiveness of interleukin-23 inhibitors in the treatment of psoriasis and psoriatic arthritis in a real-world setting. The results showed that these drugs have high and similar drug survival and effectiveness in patients with difficult-to-treat psoriasis and PsA.

JOURNAL OF DERMATOLOGICAL TREATMENT (2023)

Article Dermatology

Secukinumab demonstrates superiority over narrow-band ultraviolet B phototherapy in new-onset moderate to severe plaque psoriasis patients: Week 52 results from the STEPIn study

Lars Iversen, Curdin Conrad, Liv Eidsmo, Antonio Costanzo, Joanna Narbutt, Andreas Pinter, Kulli Kingo, Raquel Rivera Diaz, Frank Kolbinger, ManikPrabhu Nanna, Jennifer Annika Frueh, Piotr Jagiello

Summary: The purpose of this study was to compare the effectiveness of early intervention with secukinumab and traditional nb-UVB phototherapy in patients with new-onset moderate to severe plaque psoriasis. The results showed that secukinumab was more effective than nb-UVB, and early use of biologic treatment may be more effective in treating psoriasis.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Dermatology

Arthritis Hit Rate in Patients with Psoriasis Referred for Rheumatology Evaluation

Catalina Hartmann Skovsgard, Trine Bay Laurberg, Anders Dige, Lars Iversen, Kasper Fjellhaugen Hjuler

Summary: The aim of this study was to determine the proportion of psoriasis patients with suspicion of PsA who are diagnosed with PsA or other rheumatologic conditions following referral from a dermatology department. A total of 23.6% of patients with psoriasis with symptoms suggestive of PsA were diagnosed with axial and/or peripheral arthritis following rheumatologic evaluation.

DERMATOLOGY (2023)

Article Dermatology

Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell

Emil M. H. Pallesen, Maria Gluud, Chella Krishna Vadivel, Terkild B. Buus, Bob de Rooij, Ziao Zeng, Sana Ahmad, Andreas Willerslev-Olsen, Christian Roehrig, Maria R. Kamstrup, Lene Bay, Lise Lindahl, Thorbjorn Krejsgaard, Carsten Geisler, Charlotte M. Bonefeld, Lars Iversen, Anders Woetmann, Sergei B. Koralov, Thomas Bjarnsholt, Johan Frieling, Mathias Schmelcher, Niels Odum

Summary: This study investigates the effect of a recombinant, antibacterial protein, endolysin (XZ.700), on S. aureus skin colonization and malignant T-cell activation in cutaneous T-cell lymphomas. The results show that endolysin strongly inhibits S. aureus proliferation in the skin of lymphoma patients and reduces bacterial cell counts in a dose-dependent manner. Moreover, endolysin also inhibits the colonization of S. aureus on healthy and lesional skin and has a significant inhibitory effect on the activation and proliferation of malignant T cells induced by S. aureus.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2023)

Article Pharmacology & Pharmacy

Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis

Cathrine Dawn Buttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler

Summary: This study investigates the drug survival and clinical effectiveness of brodalumab in real-world patients with psoriasis and psoriatic arthritis. The results show that brodalumab is effective in treating these conditions, but the drug survival rate is lower compared to other studies.

DRUGS IN R&D (2023)

Article Immunology

Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation

Hakim Ben Abdallah, Sabine Seeler, Anne Bregnhoj, Gautam Ghatnekar, Lasse S. Kristensen, Lars Iversen, Claus Johansen

Summary: RGRN-305, an HSP90 inhibitor, exhibits anti-inflammatory effects by suppressing key proinflammatory cytokines and signaling pathways in TPA-induced skin inflammation. This study suggests that HSP90 inhibition may be a novel mechanism of action for treating immune-mediated skin diseases beyond psoriasis, and it may serve as a topical treatment option.

FRONTIERS IN IMMUNOLOGY (2023)

Article Biochemistry & Molecular Biology

Single-Particle Tracking of Thermomyces lanuginosus Lipase Reveals How Mutations in the Lid Region Remodel Its Diffusion

Josephine F. F. Iversen, Soren S. -R. Bohr, Henrik D. D. Pinholt, Matias E. E. Moses, Lars Iversen, Sune M. M. Christensen, Nikos S. S. Hatzakis, Min Zhang

Summary: We investigated the diffusion behavior of Thermomyces lanuginosus lipase (TLL) variants with different lid structures in a laundry-like application condition using single-particle tracking (SPT). Our findings reveal that surface binding and lipase mobility when bound are crucial factors affecting the overall activity variation in the application condition. These mechanistic insights provide new perspectives on the development of enzyme-based detergents.

BIOMOLECULES (2023)

Article Biology

Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases

Marlene Uglebjerg Fruergaard, Christine Juul Faelled Nielsen, Cecilia Rosada Kjeldsen, Lars Iversen, Jacob Lauwring Andersen, Poul Nissen

Summary: The p90 ribosomal S6 kinases (RSKs) consist of N-terminal and C-terminal kinase domains (NTKD and CTKD). CTKD activation is regulated by phosphorylation by extracellular signal-regulated kinase (ERK1/2) and an autoinhibitory alpha L helix. Through mutational experiments, a mechanism of lifting autoinhibition was discovered, leading to the design of constitutively active RSK CTKDs. These findings provide insights into the characterization of inhibitors and determination of specificity constants of covalent CTKD inhibitors.

LIFE SCIENCE ALLIANCE (2023)

Article Dermatology

Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies

Mark Lebwohl, Lars Iversen, Liv Eidsmo, James G. Krueger, Mayte Suarez-Farinas, Lewis Tomalin, Frank Kolbinger, Ruquan You, Marina Milutinovic

Summary: A proportion of patients stayed relapse-free following discontinuation of secukinumab, and patients with shorter disease duration remained relapse-free for longer, suggesting that earlier treatment with secukinumab may result in long-term clinical control of moderate-to-severe psoriasis.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2023)

Review Dermatology

Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review

Tiago Torres, Jordi Galvan, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, Jose Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter

Summary: Topical treatment of psoriasis is important but non-adherence is a challenge. CAL/BDP PAD-cream, based on PAD Technology, offers a more convenient and effective treatment. This formulation ensures stability, increases penetration, and improves cosmetic acceptability. Clinical trials have shown high efficacy, safety, and patient satisfaction with CAL/BDP PAD-cream, potentially leading to improved adherence and outcomes.

DERMATOLOGY AND THERAPY (2023)

Article Dermatology

Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries

Flora Nicol Balieva, Louise Catton, Birgitta W. W. Clareus, Kjersti Danielsen, Frederik Fierens, Lars Iversen, Leena Koulu, Amra Osmanecevic, Rafael Pasternack, Lone Skov

Summary: This study aimed to explore treatment preferences and patient characteristics in young bio-naive adults with moderate to severe psoriasis in the Nordic countries. The interviews revealed that patient preferences focused on both symptom relief and reducing the burden of treatment. Understanding the reasons behind these preferences is crucial for individualized psoriasis management.

DERMATOLOGY AND THERAPY (2023)

暂无数据